RVL Pharma plummets on bankruptcy reorganization plan
** Shares of drugmaker RVL Pharmaceuticals RVLP.O fall
~33.7% to 10 cents premarket
** Co says it is reorganizing some of its U.S operating
units through prepackaged bankruptcy cases
** Says the reorganization will help with debt reduction and
allow the units to further invest in co's eye drop Upneeq
** Up to last close, shares down 86% YTD
(Reporting by Christy Santhosh)
((Christy.Santhosh@thomsonreuters.com))
Recent news on RVL Pharmaceuticals
See all newsBrief: RVL Pharmaceuticals Says High Court Of Ireland Made A Winding Up Order In Respect Of Co On Feb 12
Brief: RVL Pharmaceuticals Says Co Issued Petition In Central Office Of High Court In Ireland To Wind Up Company
Brief: RVL Completes Financial Restructuring
Brief: Rvl Pharmaceuticals PLC Received Delisting Notice From Listing Qualifications Department Of Nasdaq Stock Market Llc
U.S. STOCKS ON THE MOVE-Cerevel Therapeutics, Scholar Rock, Helius